With the revival of psychedelic research for mental health in the past few years, there has been no shortage of published findings demonstrating the positive and promising possibilities of psychedelic therapies in the treatment of a variety of challenges including Treatment-Resistant Depression (TRD), Anxiety, Addiction, and PTSD to name a few. The bulk of these studies have involved multiple facilitated sessions with large doses, as well as microdosing over many weeks demonstrating verifiable changes in the brain, but what are the effects of a single dose?
PsyPost recently highlighted details of research by a Danish team that found a measurable boost in the neural connections of the brain following a single dose of psilocybin.
“We find that a single dose of psilocybin increases the presynaptic marker SV2A already after one day and that it remains higher seven days after,” the researchers said, adding that the “increased levels of SV2A after intervention with a psychedelic drug adds to the scientific evidence that psychedelics enhance neuroplasticity, which may explain the mechanism of action of its antidepressant properties.”
